ÃØÃÜÑо¿Ëù

Internal Server Error
Unlock full details of this profile with our free LiteÌý±è±ô²¹²Ô!
Sign Up and Get Free Access

Last updated:

Aplagon - About the company

Aplagon is a series A company based in Helsinki (Finland), founded in 2009 by , and . It operates as a Heparin peptidoglycan mimetics for treating complications of vascular intervention-related blood vessel occlusions.. Aplagon has raised $7.24M in funding from Innovestor and FÃ¥hraeus Startup and Growth Fund. The company has 4 active competitors, including 2 that are funded. Its top competitors are Emosis, Thrombosis DNA and Retham Technologies.

Company Details

Aplagon is a Finnish, preclinical stage biotech developing Heparin peptidoglycan mimetics for treating complications of vascular intervention-related blood vessel occlusions. The Heparin peptidoglycan mimetics, are called APACs and are proprietary, locally acting, potent antithrombotic products, which target blood vessel wall injury. APACs, which were discovered by Aplagon scientists, are indicated for the prevention and management of both the short- and long -term complications of vascular intervention-related blood vessel occlusions.
Website
Phone Number
+358
Key Metrics
Founded Year
2009
Location
Helsinki, Finland
Stage
Series A
Total Funding
in 4 rounds
Latest Funding Round
Investors
Ranked
1st among
Similar Companies
Get your free copy of Aplagon's company profile

Aplagon's funding and investors

Aplagon has raised a total funding of $7.24M over 4 rounds. Its first funding round was on Dec 07, 2018. Its latest funding round was a Series A round on Feb 03, 2025 for $7.24M. 5 investors participated in its latest round, lead by FÃ¥hraeus Startup and Growth Fund.

Aplagon has 7 institutional investors including Innovestor, FÃ¥hraeus Startup and Growth Fund and .

Here is the list of recent funding rounds of Aplagon:
Date of funding
Funding Amount
Round Name
Post money valuation
Revenue multiple
Investors
Feb 03, 2025
$7.24M
Series A
4527651
4134385
Sep 01, 2022
$2.09M
Grant (prize money)
1424944
3288852
2022
$10.1M
Grant (prize money)
7174
7996
lockAccess funding benchmarks and valuations. Sign up today!

Aplagon's founders and board of directors

The founders of Aplagon are , and . is the CEO of Aplagon.
Here are the details of Aplagon's key team members:
  • : Co-Founder of Aplagon.
  • : Co-Founder of Aplagon.
  • : Co-Founder of Aplagon.
  • : CEO of Aplagon.
    Contact Info:
View details of
chrome_extension_cta_illustration
Access ÃØÃÜÑо¿Ëù on any website
Our Google Chrome extension lets you view company details while browsing their websites

Aplagon's Competitors and alternates

Top competitors of Aplagon include Emosis, Thrombosis DNA and Retham Technologies. Here is the list of Top 10 competitors of Aplagon, ranked by ÃØÃÜÑо¿Ëù score:
Overall Rank
Company Details
Short Description
Total Funding
Investors
ÃØÃÜÑо¿Ëù Score
1st
Logo for Aplagon
2009, Helsinki (Finland), Series A
Heparin peptidoglycan mimetics for treating complications of vascular intervention-related blood vessel occlusions.
$7.24M
, EIC FundÌý&²¹³¾±è;Ìý
47/100
2nd
Logo for Emosis
Emosis
2015, Strasbourg (France), Series A
Developing flowcytometer-based test kits for the diagnosis of hemostasis disorders
$1.11M
22/100
3rd
Logo for Thrombosis DNA
Thrombosis DNA
2015, Unfunded
Developer of DNA test panel for detecting risk of thrombosis
-
-
18/100
4th
Logo for Retham Technologies
Retham Technologies
2017, Wauwatosa (United States), Funding Raised
Developer of diagnosis and management of blood clotting disorder
-
11/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Aplagon's competitors? Click to see the top ones

Aplagon's Investments and acquisitions

Aplagon has made no investments or acquisitions yet.

Reports related to Aplagon

Here is the latest report on Aplagon's sector:
View

News related to Aplagon

Media has covered Aplagon for 1 event in last 1 year.
•
FinSMEs•Feb 03, 2025•Aplagon, Fåhraeus Startup and Growth Fund, , and 4 others
•
b3cnewswire.com•Sep 19, 2017•Aplagon,
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!
Are you a Founder ?

FAQ's about Aplagon

Explore our recently published companies
  • AKG - Sydney based, 1991 founded, Unfunded company
  • EGFL - Mumbai based, 1969 founded, Public company
  • Cornish Cider Company - York based, 2018 founded, Funding Raised company
ÃØÃÜÑо¿Ëù powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USPalo Alto NetworkMaersk GrowthFujitsuTenityStanford